Table 1 Patient information and tumor characteristics
From: Clinical value and mechanism of CDKN2A in clear cell renal cell carcinoma
Parameters | Values |
|---|---|
Total number of patients | 75 |
Male proportion (%) | 50(66.7%) |
Age at the time of surgery (years) | 65(34–82) |
Maximum tumor diameter (cm) | 6.4(1.2–15) |
Proportion of right kidney | 38(50.7%) |
TNM stage | |
Stage I | 35(46.7%) |
Stage II | 18(24%) |
Stage III | 16(21.3%) |
Stage IV | 6(8%) |
T stage | |
T1a | 19(25.3%) |
T1b | 17(22.7%) |
T2a | 15(20%) |
T2b | 3(4%) |
T3 | 17(22.7%) |
T4 | 4(5.3%) |
N stage | |
N0 | 74(98.7%) |
N1 | - |
M stage | |
M0 | 73(97.3%) |
M1 | 2(2.7%) |